Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIDCR

AAV Mediated Aquarporin-1 Gene Transfer To Treat Sjogren's Syndrome

  • Read more about AAV Mediated Aquarporin-1 Gene Transfer To Treat Sjogren's Syndrome
US Application 61/695,753
Filed on 2012-08-31

Inhibition Of Metastasis with ROCK Inhibitors

  • Read more about Inhibition Of Metastasis with ROCK Inhibitors
US Application 61/536,434
Filed on 2011-09-19

DIFFERENTIALLY-EXPRESSED GENE PRODUCTS FOR USE IN THE DIAGNOSIS AND TREATMENT OF SJOGREN'S SYNDROME

  • Read more about DIFFERENTIALLY-EXPRESSED GENE PRODUCTS FOR USE IN THE DIAGNOSIS AND TREATMENT OF SJOGREN'S SYNDROME
US Application 61/556,729
Filed on 2011-11-07

Methods for the Diagnosis And Treatment Of Sjogren's Syndrome

  • Read more about Methods for the Diagnosis And Treatment Of Sjogren's Syndrome
US Application 61/540,364
Filed on 2011-09-28

AAV Mediated Exendin-4 Gene Transfer To Salivary Glands To Protect Subjects From Diabetes Or Obesity

  • Read more about AAV Mediated Exendin-4 Gene Transfer To Salivary Glands To Protect Subjects From Diabetes Or Obesity
US Application 61/477,523
Filed on 2011-04-20

AAV Mediated CTLA-4 Gene Transfer to Treat Sjogren's Syndrome

  • Read more about AAV Mediated CTLA-4 Gene Transfer to Treat Sjogren's Syndrome
US Application 61/476,168
Filed on 2011-04-15

Differentially-Expressed Gene Products For Use In The Diagnosis And Treatment of Sjogren's Syndrome

  • Read more about Differentially-Expressed Gene Products For Use In The Diagnosis And Treatment of Sjogren's Syndrome
US Application 61/476,192
Filed on 2011-04-15

Stem cell-mediated angiogenesis therapy for bisphosphonate-induced osteonecrosis of the jaw

  • Read more about Stem cell-mediated angiogenesis therapy for bisphosphonate-induced osteonecrosis of the jaw
US Application 61/263,441
Filed on 2009-11-23

Composition and Mehtods for Screening for Lyme Diseasee

  • Read more about Composition and Mehtods for Screening for Lyme Diseasee
US Application 61/312,520
Filed on 2010-03-10

INTEGRIN CD18 IS A NOVEL STROMAL STEM CELL MARKER AND FUNCTIONS TO PROMOTE OSTEOGENESIS

  • Read more about INTEGRIN CD18 IS A NOVEL STROMAL STEM CELL MARKER AND FUNCTIONS TO PROMOTE OSTEOGENESIS
US Application 60/690,767
Filed on 2005-06-15

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIDCR
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health